Cooperating Commensals Restore Colonization Resistance to Vancomycin-Resistant Enterococcus faecium

Cell Host and Microbe

Volumn 21, Issue 5, 2017, Pages 592-602.e4

  Caballero, Silvia ^a,b   Kim, Sohn ^a   Carter, Rebecca A ^a   Leiner, Ingrid M ^a   Sušac, Bože ^a   Miller, Liza ^a   Kim, Grace J ^a   Ling, Lilan ^a   Pamer, Eric G ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

antibiotic resistance; Blautia product; colonization resistance; commensal bacteria; Enterococcus; Enterococcus faecium; intestinal domination; microbiome; microbiota; vancomycin resistance

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; BACTERIAL DNA; RNA 16S; VANCOMYCIN;

ANIMAL; ANTIBIOTIC RESISTANCE; BACTERIAL COUNT; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIUM; C57BL MOUSE; CLOSTRIDIUM; ENTEROCOCCUS FAECIUM; FECES; FEMALE; GENETICS; GRAM POSITIVE INFECTION; GROWTH, DEVELOPMENT AND AGING; INTESTINE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; MOUSE; PATHOGENICITY; PHYSIOLOGY; SYMBIOSIS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

AMPICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; CLOSTRIDIUM; COLONY COUNT, MICROBIAL; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECIUM; FECES; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; INTESTINES; MICE; MICE, INBRED C57BL; MICROBIOTA; RNA, RIBOSOMAL, 16S; SYMBIOSIS; VANCOMYCIN; VANCOMYCIN-RESISTANT ENTEROCOCCI;

EID: 85019136323     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2017.04.002     Document Type: Article

References (45)

1. Abt, M.C., Buffie, C.G., Sušac, B., Becattini, S., Carter, R.A., Leiner, I., Keith, J.W., Artis, D., Osborne, L.C., Pamer, E.G., TLR-7 activation enhances IL-22-mediated colonization resistance against vancomycin-resistant enterococcus. Sci. Transl. Med., 8, 2016, 327ra25.
2. Arias, C.A., Murray, B.E., Emergence and management of drug-resistant enterococcal infections. Expert Rev. Anti Infect. Ther. 6 (2008), 637–655.
3. Arias, C.A., Murray, B.E., The rise of the Enterococcus: beyond vancomycin resistance. Nat. Rev. Microbiol. 10 (2012), 266–278.
4. Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500 (2013), 232–236.
5. Blair, J.M., Webber, M.A., Baylay, A.J., Ogbolu, D.O., Piddock, L.J., Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol. 13 (2015), 42–51.
6. Brandl, K., Plitas, G., Mihu, C.N., Ubeda, C., Jia, T., Fleisher, M., Schnabl, B., DeMatteo, R.P., Pamer, E.G., Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455 (2008), 804–807.
7. Brugiroux, S., Beutler, M., Pfann, C., Garzetti, D., Ruscheweyh, H.-J., Ring, D., Diehl, M., Herp, S., Lötscher, Y., Hussain, S., et al. Genome-guided design of a defined mouse microbiota that confers colonization resistance against Salmonella enterica serovar Typhimurium. Nat. Microbiol., 2, 2016, 16215.
8. Buffie, C.G., Bucci, V., Stein, R.R., McKenney, P.T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517 (2015), 205–208.
9. Caballero, S., Carter, R., Ke, X., Sušac, B., Leiner, I.M., Kim, G.J., Miller, L., Ling, L., Manova, K., Pamer, E.G., Distinct but Spatially Overlapping Intestinal Niches for Vancomycin-Resistant Enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniae. PLoS Pathog., 11, 2015, e1005132.
10. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States. 2013, CDC https://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf.
11. Derrien, M., Vaughan, E.E., Plugge, C.M., de Vos, W.M., Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int. J. Syst. Evol. Microbiol. 54 (2004), 1469–1476.
12. Desai, M.S., Seekatz, A.M., Koropatkin, N.M., Kamada, N., Hickey, C.A., Wolter, M., Pudlo, N.A., Kitamoto, S., Terrapon, N., Muller, A., et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167 (2016), 1339–1353.e21.
13. DeSantis, T.Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E.L., Keller, K., Huber, T., Dalevi, D., Hu, P., Andersen, G.L., Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72 (2006), 5069–5072.
14. Dethlefsen, L., Huse, S., Sogin, M.L., Relman, D.A., The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol., 6, 2008, e280.
15. Donskey, C.J., Chowdhry, T.K., Hecker, M.T., Hoyen, C.K., Hanrahan, J.A., Hujer, A.M., Hutton-Thomas, R.A., Whalen, C.C., Bonomo, R.A., Rice, L.B., Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N. Engl. J. Med. 343 (2000), 1925–1932.
16. Dubberke, E.R., Mullane, K.M., Gerding, D.N., Lee, C.H., Louie, T.J., Guthertz, H., Jones, C., Clearance of Vancomycin-Resistant Enterococcus Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent Clostridium difficile Infection. Open Forum Infect. Dis., 3, 2016, ofw133.
17. Earle, K.A., Billings, G., Sigal, M., Lichtman, J.S., Hansson, G.C., Elias, J.E., Amieva, M.R., Huang, K.C., Sonnenburg, J.L., Quantitative Imaging of Gut Microbiota Spatial Organization. Cell Host Microbe 18 (2015), 478–488.
18. Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S.R., Nelson, K.E., Relman, D.A., Diversity of the human intestinal microbial flora. Science 308 (2005), 1635–1638.
19. Edgar, R.C., Haas, B.J., Clemente, J.C., Quince, C., Knight, R., UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27 (2011), 2194–2200.
20. Flint, H.J., Scott, K.P., Duncan, S.H., Louis, P., Forano, E., Microbial degradation of complex carbohydrates in the gut. Gut Microbes 3 (2012), 289–306.
21. Kinnebrew, M.A., Ubeda, C., Zenewicz, L.A., Smith, N., Flavell, R.A., Pamer, E.G., Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J. Infect. Dis. 201 (2010), 534–543.
22. Lawley, T.D., Clare, S., Walker, A.W., Stares, M.D., Connor, T.R., Raisen, C., Goulding, D., Rad, R., Schreiber, F., Brandt, C., et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog., 8, 2012, e1002995.
23. Lee, H.H., Molla, M.N., Cantor, C.R., Collins, J.J., Bacterial charity work leads to population-wide resistance. Nature 467 (2010), 82–85.
24. Lozupone, C., Lladser, M.E., Knights, D., Stombaugh, J., Knight, R., UniFrac: an effective distance metric for microbial community comparison. ISME J. 5 (2011), 169–172.
25. Marcobal, A., Barboza, M., Sonnenburg, E.D., Pudlo, N., Martens, E.C., Desai, P., Lebrilla, C.B., Weimer, B.C., Mills, D.A., German, J.B., Sonnenburg, J.L., Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host Microbe 10 (2011), 507–514.
26. McKenney, P.T., Pamer, E.G., From hype to hope: the gut microbiota in enteric infectious disease. Cell 163 (2015), 1326–1332.
27. Medaney, F., Dimitriu, T., Ellis, R.J., Raymond, B., Live to cheat another day: bacterial dormancy facilitates the social exploitation of β-lactamases. ISME J. 10 (2016), 778–787.
28. Ng, K.M., Ferreyra, J.A., Higginbottom, S.K., Lynch, J.B., Kashyap, P.C., Gopinath, S., Naidu, N., Choudhury, B., Weimer, B.C., Monack, D.M., Sonnenburg, J.L., Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502 (2013), 96–99.
29. Pamer, E.G., Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns. Mucosal Immunol. 7 (2014), 210–214.
30. Petrof, E.O., Gloor, G.B., Vanner, S.J., Weese, S.J., Carter, D., Daigneault, M.C., Brown, E.M., Schroeter, K., Allen-Vercoe, E., Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut. Microbiome, 1, 2013, 3.
31. Pultz, N.J., Stiefel, U., Subramanyan, S., Helfand, M.S., Donskey, C.J., Mechanisms by which anaerobic microbiota inhibit the establishment in mice of intestinal colonization by vancomycin-resistant Enterococcus. J. Infect. Dis. 191 (2005), 949–956.
32. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., Yamada, T., et al., MetaHIT Consortium. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (2010), 59–65.
33. Rakoff-Nahoum, S., Foster, K.R., Comstock, L.E., The evolution of cooperation within the gut microbiota. Nature 533 (2016), 255–259.
34. Reeves, A.E., Koenigsknecht, M.J., Bergin, I.L., Young, V.B., Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae. Infect. Immun. 80 (2012), 3786–3794.
35. Reikvam, D.H., Erofeev, A., Sandvik, A., Grcic, V., Jahnsen, F.L., Gaustad, P., McCoy, K.D., Macpherson, A.J., Meza-Zepeda, L.A., Johansen, F.E., Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression. PLoS One, 6, 2011, e17996.
36. Savage, D.C., Dubos, R., Alterations in the mouse cecum and its flora produced by antibacterial drugs. J. Exp. Med. 128 (1968), 97–110.
37. Schloss, P.D., Westcott, S.L., Ryabin, T., Hall, J.R., Hartmann, M., Hollister, E.B., Lesniewski, R.A., Oakley, B.B., Parks, D.H., Robinson, C.J., et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75 (2009), 7537–7541.
38. Sheneman, L., Evans, J., Foster, J.A., Clearcut: a fast implementation of relaxed neighbor joining. Bioinformatics 22 (2006), 2823–2824.
39. Taur, Y., Xavier, J.B., Lipuma, L., Ubeda, C., Goldberg, J., Gobourne, A., Lee, Y.J., Dubin, K.A., Socci, N.D., Viale, A., et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin. Infect. Dis. 55 (2012), 905–914.
40. Tvede, M., Tinggaard, M., Helms, M., Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000-2012. Clin. Microbiol. Infect. 21 (2015), 48–53.
41. Ubeda, C., Taur, Y., Jenq, R.R., Equinda, M.J., Son, T., Samstein, M., Viale, A., Socci, N.D., van den Brink, M.R., Kamboj, M., Pamer, E.G., Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J. Clin. Invest. 120 (2010), 4332–4341.
42. Ubeda, C., Lipuma, L., Gobourne, A., Viale, A., Leiner, I., Equinda, M., Khanin, R., Pamer, E.G., Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. J. Exp. Med. 209 (2012), 1445–1456.
43. Ubeda, C., Bucci, V., Caballero, S., Djukovic, A., Toussaint, N.C., Equinda, M., Lipuma, L., Ling, L., Gobourne, A., No, D., et al. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect. Immun. 81 (2013), 965–973.
44. Wlodarska, M., Willing, B., Keeney, K.M., Menendez, A., Bergstrom, K.S., Gill, N., Russell, S.L., Vallance, B.A., Finlay, B.B., Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect. Immun. 79 (2011), 1536–1545.
45. Yurtsev, E.A., Chao, H.X., Datta, M.S., Artemova, T., Gore, J., Bacterial cheating drives the population dynamics of cooperative antibiotic resistance plasmids. Mol. Syst. Biol., 9, 2013, 683.